Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Cotter Ann Marie	2. Issuer Name and Ticker or Trading Symbol Zomedica Corp. [ ZOM ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) CFO and Secretary
(Last)          (First)          (Middle) C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125	3. Date of Earliest Transaction (MM/DD/YYYY) 4/12/2021
(Street) ANN ARBOR, MI 48018 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, without par value	4/12/2021		M		33332	A	$.19	33332	D
Common Stock, without par value	4/12/2021		S(1)		33332	D	$1.1567	0	D
Common Stock, without par value	4/12/2021		M		25000	A	$.11	25000	D
Common Stock, without par value	4/12/2021		S(1)		25000	D	$1.1567	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	$0.19	4/12/2021		M			33332	(2)	3/14/2025	Common Stock, without par value	33332	$0	166668	D
Stock option (right to buy)	$0.11	4/12/2021		M			25000	(3)	10/1/2025	Common Stock, without par value	25000	$0	275000	D

Explanation of Responses:
(1)	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
(2)	The option vest as to 25% on March 14, 2020, with 25% to vest annually thereafter.
(3)	The option vests in 4 equal annual installments commencing October 1, 2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Cotter Ann Marie C/O ZOMEDICA CORP. 100 PHOENIX DRIVE, SUITE 125 ANN ARBOR, MI 48018			CFO and Secretary

Signatures
/s/ John Hogoboom, attorney-in-fact		4/13/2021
**Signature of Reporting Person		Date